Merck & Co., Inc. (MRK) Stock Price Movement:In recent trading day Merck & Co., Inc. (MRK) stock showed the move of 0.78% with the closing price of $55.36. Closing price generally refers to the last price at which a stock trades during a regular trading session. The company moved in the past week with shift of 2.01%. Over the last three months, the shares of the company have changed -12.29% and performed -15.17% over the last six months. Return on equity reveals how much profit a company earned in comparison to the total amount of shareholder equity found on the balance sheet. It has a return on equity (ROE) of 7.20%. Tracking ROA value which gives an idea as to how efficient management is at using its assets to generate earnings. The firm has a Return on Assets (ROA) value of 3.00%. However it has a net margin of 7.20%. Its Average True Range (ATR) shows a figure of 0.92. The stock currently has Monthly Volatility of 1.28% and Weekly Volatility of 1.01%. The Beta for the stock stands at 0.79. The stock’s Dividend Yield stands at 3.40%. The consensus recommendation for stock is 2.20. The rating scale runs from 1 to 5 with 5 indicating a Strong Sell, 1 indicating a Strong Buy and 3 indicating a Hold. Technical Indicators Summary: Investors and Traders continue to monitor technical levels of shares of Merck & Co., Inc. (MRK). A frequently used tool among technical stock analysts is the moving average. Moving averages are considered to be lagging indicators that simply take the average price of a stock over a certain period of time. Moving averages can be very helpful for identifying peaks and troughs. They may also be used to assist the trader figure out proper support and resistance levels for the stock. The stock closing price is currently trading downward to its 50 day moving average with change of -8.13%, escalated to its 20 day moving average with figure of 0.34% and behind its 200 day moving average with value -12.06%. The share last price represents downtick move of -17.13% in value from company’s 52-Week high price and shows 3.23% above change in value from its 52-Week low price. Checking in on some other technical levels, the 14-day RSI is currently at 37.74. Sarepta Therapeutics, Inc. (SRPT) stock moved with shift of -3.78% in the past week. During the last month, the stock has changed 12.08% and performed 75.05% over the last 6 months. The Volatility was noted at 3.74% in recent month and it observed Weekly Volatility of 2.87%. The Beta factor for the stock is listed at 1.33. The mean rating score for this stock is at 1.70. In current trading day Sarepta Therapeutics, Inc. (SRPT) stock confirmed the flow of -3.61% with the final price of $53.74. Its Average True Range (ATR) value figured out at 2.01. It has a Return on Investment (ROI) of -75.60% and a gross margin of 96.10%. Technical Snapshot: The last closing stock price represents a downfall of -6.65% in price from company’s fifty two-Week high price and indicates a 104.65% above from its 52-Week low price. The recent closing stock price gained 39.26% when it compared to 200-day moving average. The stock share price dropped -0.88% comparing to its 20-day moving average. The stock price is moving upward 5.37% to its 50-day moving average. A simple moving average (SMA) is an arithmetic moving average calculated by adding the closing price of the security for a number of time periods and then dividing this total by the number of time periods. A simple moving average smoothes out volatility, and makes it easier to view the price trend of a security. If the simple moving average points up, this means that the security’s price is increasing. If it is pointing down it means that the security’s price is decreasing. The longer the timeframe for the moving average, the smoother the simple moving average. A shorter-term moving average is more volatile but its reading is closer to the source data. Ross Arlen works as co-editor and cover breaking news. In the past, he has written for other financial sites and published independent investment research, primarily on Healthcare & Biotech Companies. He trains staff on the finer points of writing, editing and getting the news out on time. He received his BBA in Accounting (With Honors) – from The University of Texas – San Antonio. His primary focus is on the effects of activity to the market. 
